Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell Matrix awarded grants for development of novel antiangiogenesis products

July 25, 2001

Patient enrollment completed in SafeScience phase II pancreatic cancer trial

July 24, 2001

VEGF inhibitors useful for angiogenesis-related disorders according to Yamanouchi

July 24, 2001

Vion's Triapine enters phase II for treatment of leukemia

July 24, 2001

Patient enrollment completed in phase I trial of Inex's INX-3280

July 24, 2001

FDA Oncologic Drugs Advisory Committee to review Zevalin at upcoming meeting

July 24, 2001

NeoOncoRx completes acquisition of Neoquin; phase II trials to commence in U.K.

July 24, 2001

Aastrom Biosciences and the Karmanos Cancer Institute create new cell therapy center

July 24, 2001

Research at U.S. university leads to new cell regulation modulators

July 23, 2001

MethylGene designs histone deacetylase inhibitors useful for cancer, restenosis, psoriasis

July 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...